Innovation Hub
/
Blog
/
Scientist Partners With AstraZeneca to Launch Virtual Research Laboratory

Scientist Partners With AstraZeneca to Launch Virtual Research Laboratory

This press release came in yesterday and we thought that this is so exciting that we wanted to blog about it. Congratulations to both, Scientist...

Sean Preci

Published on

July 31, 2012

This press release came in yesterday and we thought that this is so exciting that we wanted to blog about it. Congratulations to both, Scientist and to AstraZeneca!

Why are we at CDD getting so excited about this particular news? Because Virtual Research is the future and some companies are not just talking about it but actually doing something for real commercial projects like this one.

Abstract molecular cluster with three connected blue-green spheres on a white background.

Take the Next Step

Explore Suppliers

Browse trusted partners with relevant expertise

Review Capabilities

Compare services, experience, and past work

Start Your Project

Connect and begin collaborating

Browse Suppliers

Post a Project

How It Works

Written by

Sean Preci

Share this post

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Topics of Interest

Biology
Biometrics
Chemical & Compound Analysis
Chemistry, Manufacturing & Controls
Clinical Trials
Discovery Chemistry
DMPK
Health Economics & Outcomes Research (HEOR)
Human Biological Samples (HBS)
Market Access
Non-Human Biological Samples (NHBS)
Pharmacology
Raw Materials
Real-World Data (RWD)
Real-World Evidence (RWE)
Safety & Pharmacovigilance
Toxicology
Medical Communications

Email address

I would like to receive the monthly Scientist.com newsletter.

I agree to receive email communication from Scientist.com and accept the data privacy statement.

By submitting your information, you agree to our Terms of Service and Privacy Policy. You can opt out anytime.

Subscribe to our newsletter

Subscribe to receive the latest news and innovations straight to your inbox.

Your subscription could not be saved. Please try again.

Your subscription has been successful.

Topics of Interest

Biology
Biometrics
Chemical & Compound Analysis
Chemistry, Manufacturing & Controls
Clinical Trials
Discovery Chemistry
DMPK
Health Economics & Outcomes Research (HEOR)
Human Biological Samples (HBS)
Market Access
Non-Human Biological Samples (NHBS)
Pharmacology
Raw Materials
Real-World Data (RWD)
Real-World Evidence (RWE)
Safety & Pharmacovigilance
Toxicology
Medical Communications

Email address

I would like to receive the monthly Scientist.com newsletter.

I agree to receive email communication from Scientist.com and accept the data privacy statement.

By submitting your information, you agree to our Terms of Service and Privacy Policy. You can opt out anytime.

Scientist Partners With AstraZeneca to Launch Virtual Research Laboratory

Take the Next Step

Explore Suppliers

Review Capabilities

Start Your Project

Subscribe to our newsletter

Subscribe to our newsletter

Read Further

The Evolving Landscape of Drug Discovery for Metabolic Diseases

Regulatory Evolution in Substantial Evidence: The FDA’s One-Trial Pathway and the Strategic Implications for Biopharmaceutical Development

June 2026 Medical/Commercial Pulse Check

Accelerating the Design–Build–Test–Learn Cycle for AI-Driven Antibody Discovery

Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery

Reducing risk in CRO studies: Choosing the right cell models for outsourced research

Cutting Months Off AAV Programs: The Synthetic DNA Shift

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

Industry Insights: Behind the Scenes of BPS Bioscience Custom R&D

Making Sustainability More "Sustainable": Driving Transformation at Scale within Biopharma

Comprehensive Plasma cell-free RNA Profiling for Superior Cancer Detection

Advanced Screening Strategies for Molecular Glue Discovery

Why Large CROs and CDMOs Should Embrace Research Orchestration Platforms - Even with Existing Pharma Clients

AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation

Supplier Spotlight: RadMD Imaging

AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.

The Science of the "Gut Feeling": Why Techs are a Lab's Best Diagnostic Tool

Supplier Spotlight: MedChemExpress

HealthEconomics.com 2026 Pulse Check – March

Cell Line-Derived Xenografts: A Reliable Platform for Preclinical Cancer Drug Testing

2026 PharmDev Roadmap: The Regulatory Shift

Five Reasons Leading CNS Programs Rely on BrainXell for Custom iPSC Models

From the Colony to the Roadmap: The FDA's New Stance on NAMs and Why it Matters

2026 PharmDev Roadmap: The Strategic Partner

2026 PharmDev Roadmap: The Predictive Model

2026 PharmDev Roadmap: The Complexity Spike

Explore FUJIFILM's Cyclic Peptide Discovery Service

2026 PharmDev Roadmap: The Resilience Pivot

The Biosecure Act: Navigating Changes in the Biopharma Supply Chain

Evolving Frontiers in Immunohistochemistry: Applications and Transformations in Modern Biotechnology

Read Further

A Breath of Not-So-Fresh Air: the Combined Effects of Air and Noise Pollution

Talking Real Science with Jared Oenick

Talking Real Science with Micaela Merrill

Talking Real Science with Ellie Siebeneck

The Digital Backbone for Modern Life Sciences